Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Not yet recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 2Warts 1Triple Negative Breast Neoplasms 1Coronavirus Infections 1COVID-19 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Ivermectin × Clear all
NCT05318469 2026-05-06

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Cedars-Sinai Medical Center

Phase 1/2 Recruiting
34 enrolled
Breast

Triple Negative Breast Neoplasms

NCT07487805 2026-03-23

ICONIC

University of Florida

Phase 2 Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT07396714 2026-02-09

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
88 enrolled

Warts

NCT04447235 2022-08-09

TITAN

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated
77 enrolled

COVID-19, Neoplasms, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡